Alexion Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $105.89 –$115.45 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen a mixed track record when it comes to estimate revision of no increase and no decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Alexion currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Alexion Pharmaceuticals, Inc. Price

Alexion Pharmaceuticals, Inc. price | Alexion Pharmaceuticals, Inc. Quote

Investors interested in the Medical - Biomedical and Genetics industry may considerAnika Therapeutics Inc. (ANIK Quick QuoteANIK - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ALXN going up? Or down? Predict to see what others think:Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>